|
Aranesp (darbepoetin alfa)
Manufactured by: Amgen Inc  This product requires a valid prescription
| |
|
Type |
Strength |
|
Quantity |
|
Price (USD) |
|
|
|
Aranesp is indicated for the treatment of anemia associated with chronic renal failure, including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
Aranesp Prefilled Syringes should be kept in its original carton to protect it from light, and stored in the refrigerator at 2° to 8° C (36° to 46° F). Do not place Aranesp in the freezer. Do not use a vial or prefilled syringe of Aranesp that has been frozen, left in light, or improperly refrigerated. It is important that Aranesp be stored and used as stated in these instructions. Contact your healthcare provider with any questions about storage.
When traveling, transport Aranesp in its original carton in an insulated container with a coolant such as blue ice. To avoid freezing, make sure the Aranesp vial or prefilled syringe does not touch the coolant. Once you arrive, your Aranesp should be placed in a refrigerator as soon as possible.
Single-dose vials are available containing 25, 40, 60, 100, 150, 200, 300, or 500 mcg of Aranesp.
Single-dose prefilled syringesare available containing 25, 40, 60, 100, 150, 200, 300, or 500 mcg of Aranesp. To reduce the risk of accidental needlesticks to users, each prefilled syringe is equipped with a needle guard that covers the needle during disposal.
|
|
|
|
